Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia
โ Scribed by J. Brice Weinberg; Alicia D. Volkheimer; Youwei Chen; Bethany E. Beasley; Ning Jiang; Mark C. Lanasa; Daphne Friedman; Gina Vaccaro; Catherine W. Rehder; Carlos M. DeCastro; David A. Rizzieri; Louis F. Diehl; Jon P. Gockerman; Joseph O. Moore; Barbara K. Goodman; Marc C. Levesque
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 442 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The MDM-2 oncoprotein exists in an autoregulatory feedback loop with the tumor suppressor protein p53. Therefore, intracellular levels of these two proteins may play important roles in cell proliferation and tumorigenesis. Several MDM-2 proteins (Mr 35-100 Kd) have been demonstrated in human cell li
T h e in vitro peripheral lymphocyte response to phytohemagglutinin (PHA) was correlated with the clinical and immunologic status in 44 patients with chronic lymphocytic leukemia. T h e mean lymphocyte response was only slightly below the normal range a t day 3 of culture in patients in remission;
## BACKGROUND. Although patients with chronic lymphocytic leukemia (CLL) have an increased risk of developing second primary malignancies, including lung carcinoma, there is virtually no information about their clinical outcomes. To evaluate this, the authors reviewed their 20-year institutional e